Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Scientists discover new potential mechanism for vision loss

Scientists discover new potential mechanism for vision loss

Pediatric acute myeloid leukemia genetic subtypes with poor outcomes show increased inflammatory cytokine signaling

Pediatric acute myeloid leukemia genetic subtypes with poor outcomes show increased inflammatory cytokine signaling

Rogue killer T cells associated with leukemia drive autoimmune diseases

Rogue killer T cells associated with leukemia drive autoimmune diseases

CAR T therapy extends its reach beyond oncology

CAR T therapy extends its reach beyond oncology

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

Caregivers’ coping strategies affect their level of distress and quality of life

Caregivers’ coping strategies affect their level of distress and quality of life

Research findings could bolster the effectiveness of immune-checkpoint therapy

Research findings could bolster the effectiveness of immune-checkpoint therapy

Automated Zebrafish screening for Myeloid Leukemia drug discovery

Automated Zebrafish screening for Myeloid Leukemia drug discovery

Study finds no differences in CAR T-cell therapy outcomes among pediatric ALL patients across different socioeconomic levels

Study finds no differences in CAR T-cell therapy outcomes among pediatric ALL patients across different socioeconomic levels

Nanotechnology platform can make solid tumor cells more receptive to immunotherapy

Nanotechnology platform can make solid tumor cells more receptive to immunotherapy

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

Hospital giant HCA fends off accusations of questionable inpatient admissions

Hospital giant HCA fends off accusations of questionable inpatient admissions

Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, trial shows

Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, trial shows

Molecular drug transporters could improve treatment of cancers and other diseases

Molecular drug transporters could improve treatment of cancers and other diseases

New review elucidates current treatment approaches for myelodysplastic syndromes

New review elucidates current treatment approaches for myelodysplastic syndromes

25 years on, varicella vaccination reports impressive success in the USA

25 years on, varicella vaccination reports impressive success in the USA

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers streamline way to manufacture CAR T-cells in just 24 hours

Researchers streamline way to manufacture CAR T-cells in just 24 hours

MTCH2 acts as a doorway for proteins into the mitochondrial membrane, study reveals

MTCH2 acts as a doorway for proteins into the mitochondrial membrane, study reveals

Bioinformatics analysis of monkeypox virus-host cell interactions

Bioinformatics analysis of monkeypox virus-host cell interactions